{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T02:37:37Z","timestamp":1793241457200,"version":"4.5.0"},"reference-count":107,"publisher":"MDPI AG","issue":"21","license":[{"start":{"date-parts":[[2020,10,31]],"date-time":"2020-10-31T00:00:00Z","timestamp":1604102400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000124","name":"Office of Research on Women's Health","doi-asserted-by":"publisher","award":["BIRCWH K12 HD 043483"],"award-info":[{"award-number":["BIRCWH K12 HD 043483"]}],"id":[{"id":"10.13039\/100000124","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000861","name":"Burroughs Wellcome Fund","doi-asserted-by":"publisher","award":["1018894"],"award-info":[{"award-number":["1018894"]}],"id":[{"id":"10.13039\/100000861","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Platelets are critical components of a number of physiologic processes, including tissue remodeling after injury, wound healing, and maintenance of vascular integrity. Increasing evidence suggests that platelets may also play important roles in cancer. In ovarian cancer, thrombocytosis, both at the time of initial diagnosis and at recurrence, has been associated with poorer prognosis. This review describes current evidence for associations between thrombocytosis and ovarian cancer prognosis and discusses the clinical relevance of platelet count thresholds and timing of assessment. In addition, we discuss several mechanisms from in vitro, in vivo, and clinical studies that may underlie these associations and recommend potential approaches for novel therapeutic targets for this lethal disease.<\/jats:p>","DOI":"10.3390\/ijms21218169","type":"journal-article","created":{"date-parts":[[2020,10,31]],"date-time":"2020-10-31T21:39:56Z","timestamp":1604180396000},"page":"8169","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Platelets, Thrombocytosis, and Ovarian Cancer Prognosis: Surveying the Landscape of the Literature"],"prefix":"10.3390","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8155-9476","authenticated-orcid":false,"given":"Demetra H.","family":"Hufnagel","sequence":"first","affiliation":[{"name":"Vanderbilt University School of Medicine, 2209 Garland Avenue, Nashville, TN 37240, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella D.","family":"Cozzi","sequence":"additional","affiliation":[{"name":"Vanderbilt University School of Medicine, 2209 Garland Avenue, Nashville, TN 37240, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta A.","family":"Crispens","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Vanderbilt University Medical Center, 1161 21st Avenue South, Nashville, TN 37232, USA"},{"name":"Vanderbilt-Ingram Cancer Center, 1301 Medical Center Drive, Nashville, TN 37232, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Beeghly-Fadiel","sequence":"additional","affiliation":[{"name":"Vanderbilt-Ingram Cancer Center, 1301 Medical Center Drive, Nashville, TN 37232, USA"},{"name":"Department of Medicine, Division of Epidemiology, Vanderbilt University Medical Center, 2525 West End Avenue, Nashville, TN 37203, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,10,31]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1160\/THS10-11-0720","article-title":"Platelets, inflammation and tissue regeneration","volume":"105","author":"Nurden","year":"2011","journal-title":"Thromb. Haemost."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"325","DOI":"10.5482\/hamo-14-11-0065","article-title":"Platelets in cancer: From basic research to therapeutic implications","volume":"35","author":"Mangin","year":"2015","journal-title":"Hamostaseologie"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s10555-014-9498-0","article-title":"Platelets and cancer: A casual or causal relationship: Revisited","volume":"33","author":"Menter","year":"2014","journal-title":"Cancer Metastasis Rev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s13045-018-0669-2","article-title":"Role of platelets and platelet receptors in cancer metastasis 06 Biological Sciences 0601 Biochemistry and Cell Biology","volume":"11","author":"Schlesinger","year":"2018","journal-title":"J. Hematol. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1002\/(SICI)1097-0142(19960615)77:12<2544::AID-CNCR18>3.0.CO;2-S","article-title":"Trousseau\u2019s syndrome in association with ovarian carcinoma","volume":"77","author":"Evans","year":"1996","journal-title":"Cancer"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.3389\/fimmu.2019.01478","article-title":"Platelet Inflammatory Response to Stress","volume":"10","author":"Cognasse","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.thromres.2007.06.002","article-title":"Role of metalloproteinases in platelet function","volume":"121","author":"Medina","year":"2008","journal-title":"Thromb. Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1160\/TH13-02-0113","article-title":"Platelets and matrix metalloproteinases","volume":"110","author":"Seizer","year":"2013","journal-title":"Thromb. Haemost."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1160\/TH03-07-0440","article-title":"Autologous platelets as a source of proteins for healing and tissue regeneration","volume":"91","author":"Anitua","year":"2004","journal-title":"Thromb. Haemost."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3346\/jkms.2014.29.4.507","article-title":"Prognostic Significance of Initial Platelet Counts and Fibrinogen Level in Advanced Non-Small Cell Lung Cancer","volume":"29","author":"Kim","year":"2014","journal-title":"J. Korean Med. Sci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1477-7819-12-37","article-title":"Preoperative thrombocytosis is a significant unfavorable prognostic factor for patients with resectable non-small cell lung cancer","volume":"12","author":"Kim","year":"2014","journal-title":"World J. Surg. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1055\/s-0037-1613413","article-title":"Impact of pretreatment thrombocytosis on survival in primary breast cancer","volume":"89","author":"Taucher","year":"2003","journal-title":"Thromb. Haemost."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/289563","article-title":"Pretreatment Thrombocytosis as a Prognostic Factor in Metastatic Breast Cancer","volume":"2013","author":"Stravodimou","year":"2013","journal-title":"Int. J. Breast Cancer"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"971","DOI":"10.3109\/0284186X.2014.1000466","article-title":"Paraneoplastic thrombocytosis independently predicts poor prognosis in patients with locally advanced pancreatic cancer","volume":"54","author":"Chadha","year":"2015","journal-title":"Acta Oncol. (Madr.)"},{"key":"ref_15","first-page":"847","article-title":"Platelets counts closely correlate with the disease-free survival interval of pancreatic cancer patients","volume":"51","author":"Suzuki","year":"2004","journal-title":"Hepatogastroenterology"},{"key":"ref_16","first-page":"4295","article-title":"Poor Prognosis Significance of Pretreatment Thrombocytosis in Patients with Colorectal Cancer: A Meta-Analysis","volume":"17","author":"Zhao","year":"2016","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3892\/etm.2014.1699","article-title":"Thrombocytosis is a significant indictor of hypercoagulability, prognosis and recurrence in gastric cancer","volume":"8","author":"Hu","year":"2014","journal-title":"Exp. Ther. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.ejso.2012.04.009","article-title":"Impact of pretreatment thrombocytosis on blood-borne metastasis and prognosis of gastric cancer","volume":"38","author":"Hwang","year":"2012","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1182\/blood-2014-03-562538","article-title":"Paraneoplastic thrombocytosis: The secrets of tumor self-promotion","volume":"124","author":"Lin","year":"2014","journal-title":"Blood"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3109\/07357907.2015.1020384","article-title":"Platelet count after chemotherapy is a predictor for outcome for ovarian cancer patients","volume":"33","author":"Eggemann","year":"2015","journal-title":"Cancer Investig."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3322\/caac.21456","article-title":"Ovarian cancer statistics, 2018","volume":"68","author":"Torre","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/S0140-6736(13)62146-7","article-title":"Ovarian cancer","volume":"384","author":"Jayson","year":"2014","journal-title":"Lancet"},{"key":"ref_23","first-page":"151","article-title":"Pathogenesis of ovarian cancer: Lessons from morphology and molecular biology and their clinical implications","volume":"27","author":"Kurman","year":"2008","journal-title":"Int. J. Gynecol. Pathol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1016\/j.ejca.2015.07.022","article-title":"Survival of women with cancers of breast and genital organs in Europe 1999\u20132007: Results of the EUROCARE-5 study","volume":"51","author":"Sant","year":"2015","journal-title":"Eur. J. Cancer"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1056\/NEJMoa1110352","article-title":"Paraneoplastic thrombocytosis in ovarian cancer","volume":"366","author":"Stone","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Cozzi, G.D., Samuel, J.M., Fromal, J.T., Keene, S., Crispens, M.A., Khabele, D., and Beeghly-Fadiel, A. (2016). Thresholds and timing of pre-operative thrombocytosis and ovarian cancer survival: Analysis of laboratory measures from electronic medical records. BMC Cancer, 16.","DOI":"10.1186\/s12885-016-2660-z"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"457","DOI":"10.5468\/ogs.2014.57.6.457","article-title":"Thrombocytosis as a prognostic marker in stage III and IV serous ovarian cancer","volume":"57","author":"Digklia","year":"2014","journal-title":"Obstet. Gynecol. Sci."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Feng, Z., Wen, H., Bi, R., Duan, Y., Yang, W., and Wu, X. (2016). Thrombocytosis and hyperfibrinogenemia are predictive factors of clinical outcomes in high-grade serous ovarian cancer patients. BMC Cancer, 16.","DOI":"10.1186\/s12885-016-2070-2"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.ygyno.2013.05.038","article-title":"Evaluating the prognostic significance of preoperative thrombocytosis in epithelial ovarian cancer","volume":"130","author":"Allensworth","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ygyno.2003.09.002","article-title":"The prognostic significance of thrombocytosis in epithelial ovarian carcinoma","volume":"92","author":"Li","year":"2004","journal-title":"Gynecol. Oncol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/jog.12151","article-title":"Prognostic significance of thrombocytosis, platelet parameters and aggregation rates in epithelial ovarian cancer","volume":"40","author":"Ma","year":"2014","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/IGC.0000000000000303","article-title":"Pretreatment plasma D-dimer, fibrinogen, and platelet levels significantly impact prognosis in patients with epithelial ovarian cancer independently of venous thromboembolism","volume":"25","author":"Man","year":"2015","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ygyno.2011.04.012","article-title":"The impact of pretreatment thrombocytosis and persistent thrombocytosis after adjuvant chemotherapy in patients with advanced epithelial ovarian cancer","volume":"122","author":"Lee","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1158\/1078-0432.CCR-14-0870","article-title":"Differential platelet levels affect response to taxane-based therapy in ovarian cancer","volume":"21","author":"Choi","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"54","DOI":"10.4103\/0377-4929.59184","article-title":"Significance of preoperative thrombocytosis in epithelial ovarian cancer","volume":"53","author":"Crasta","year":"2010","journal-title":"Indian J. Pathol. Microbiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jpag.2007.09.004","article-title":"Thrombocytosis Associated with Malignant Ovarian Lesions within a Pediatric\/Adolescent Population","volume":"21","author":"Haddad","year":"2008","journal-title":"J. Pediatr. Adolesc. Gynecol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"12079","DOI":"10.1007\/s13277-016-5090-2","article-title":"Usefulness of the preoperative platelet count in the diagnosis of adnexal tumors","volume":"37","author":"Watrowski","year":"2016","journal-title":"Tumor Biol."},{"key":"ref_38","first-page":"517","article-title":"Diagnostic value of thrombocytosis and high CA 125 level in women with adnexal masses","volume":"33","author":"Atacag","year":"2012","journal-title":"Eur. J. Gynaecol. Oncol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1097\/AOG.0000000000001138","article-title":"Association of Preoperative Thrombocytosis and Leukocytosis With Postoperative Morbidity and Mortality Among Patients With Ovarian Cancer","volume":"126","author":"Barber","year":"2015","journal-title":"Obstet. Gynecol."},{"key":"ref_40","unstructured":"ClinicalTrials.gov [Internet] (2020, September 16). Bethesda (MD): National Library of Medicine (US). 2000 Feb 29. Identifier NCT03378297, IMPACT: A Randomized WOO Study of Novel Therapeutic Agents in Women Triaged to Primary Surgery for EOC, Available online: https:\/\/clinicaltrials.gov."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S1470-2045(18)30373-5","article-title":"Pre-diagnosis and post-diagnosis use of common analgesics and ovarian cancer prognosis (NHS\/NHSII): A cohort study","volume":"19","author":"Merritt","year":"2018","journal-title":"Lancet Oncol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ygyno.2018.06.018","article-title":"Non-aspirin NSAID use and ovarian cancer mortality","volume":"150","author":"Verdoodt","year":"2018","journal-title":"Gynecol. Oncol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.gore.2018.06.004","article-title":"Aspirin use correlates with survival in women with clear cell ovarian cancer","volume":"25","author":"Wield","year":"2018","journal-title":"Gynecol. Oncol. Rep."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.3802\/jgo.2019.30.e5","article-title":"Association of pretreatment thrombocytosis with prognosis in ovarian cancer: A systematic review and meta-analysis","volume":"30","author":"Ye","year":"2019","journal-title":"J. Gynecol. Oncol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00404-016-4212-9","article-title":"Preoperative elevated platelet count and thrombocytosis in gynecologic malignancies","volume":"295","author":"Menczer","year":"2017","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.ygyno.2015.09.017","article-title":"Is thrombocytosis a valid indicator of advanced stage and high mortality of gynecological cancer?","volume":"139","author":"Andersen","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"731","DOI":"10.5604\/12321966.1185785","article-title":"The prognostic significance of thrombocytosis in ovarian cancer","volume":"22","author":"Kozakiewicz","year":"2015","journal-title":"Ann. Agric. Environ. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s13048-020-00682-z","article-title":"Platelet count as a biomarker for monitoring treatment response and disease recurrence in recurrent epithelial ovarian cancer","volume":"13","author":"Hu","year":"2020","journal-title":"J. Ovarian Res."},{"key":"ref_49","first-page":"82","article-title":"Ovarian carcinoma associated thrombocytosis. Correlation with prognostic factors and with survival","volume":"19","author":"Menczer","year":"1998","journal-title":"Eur. J. Gynaecol. Oncol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0002-9378(94)70225-X","article-title":"Significance of thrombocytosis in patients with epithelial ovarian cancer","volume":"170","author":"Zeimet","year":"1994","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/j.1447-0756.2011.01780.x","article-title":"Preoperative plasma fibrinogen, platelet count and prognosis in epithelial ovarian cancer","volume":"38","author":"Qiu","year":"2012","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13048-020-00651-6","article-title":"Pretreatment thrombocytosis as an independent predictive factor for chemoresistance and poor survival in epithelial ovarian cancer","volume":"13","author":"Nakao","year":"2020","journal-title":"J. Ovarian Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00404-008-0673-9","article-title":"The role of thrombocytosis in prognostic evaluation of epithelial ovarian tumors","volume":"279","author":"Gungor","year":"2009","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"933","DOI":"10.7314\/APJCP.2015.16.3.933","article-title":"Prognostic significance of preoperative anemia, leukocytosis and thrombocytosis in chinese women with epithelial ovarian cancer","volume":"16","author":"Chen","year":"2015","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1016\/j.ejca.2015.07.012","article-title":"Venous thromboembolism, interleukin-6 and survival outcomes in patients with advanced ovarian clear cell carcinoma","volume":"51","author":"Matsuo","year":"2015","journal-title":"Eur. J. Cancer"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13048-019-0544-y","article-title":"Combined score of pretreatment platelet count and CA125 level (PLT-CA125) stratified prognosis in patients with FIGO stage IV epithelial ovarian cancer","volume":"12","author":"Chen","year":"2019","journal-title":"J. Ovarian Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.4103\/njcp.njcp_134_19","article-title":"Prognostic impact of pretreatment thrombocytosis in epithelial ovarian cancer","volume":"23","author":"Okunade","year":"2020","journal-title":"Niger. J. Clin. Pract."},{"key":"ref_58","first-page":"1495","article-title":"Thrombocytosis in advanced epithelial ovarian cancer","volume":"90","author":"Soonthornthum","year":"2007","journal-title":"J. Med. Assoc. Thail."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1136\/ijgc-2019-000492","article-title":"Pre-treatment prognostic nutritional index is superior to platelet count in predicting disease-specific survival in patients with epithelial ovarian cancer","volume":"29","author":"Komura","year":"2019","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"97464","DOI":"10.18632\/oncotarget.22136","article-title":"Platelet microparticle-mediated transfer of miR-939 to epithelial ovarian cancer cells promotes epithelial to mesenchymal transition","volume":"8","author":"Tang","year":"2017","journal-title":"Oncotarget"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s00508-018-1388-y","article-title":"Prognostic value of preoperative hyponatremia and thrombocytosis in patients with epithelial ovarian cancer","volume":"130","author":"Grimm","year":"2018","journal-title":"Wien. Klin. Wochenschr."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1471-0528.2008.02033.x","article-title":"The prediction of progression-free and overall survival in women with an advanced stage of epithelial ovarian carcinoma","volume":"116","author":"Gerestein","year":"2009","journal-title":"BJOG An Int. J. Obstet. Gynaecol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.ygyno.2014.01.003","article-title":"Thrombocytosis at secondary cytoreduction for recurrent ovarian cancer predicts suboptimal resection and poor survival","volume":"132","author":"Cohen","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1007\/s00404-020-05529-y","article-title":"Prognostic role of thrombocytosis in recurrent ovarian cancer: A pooled analysis of the AGO Study Group","volume":"301","author":"Canzler","year":"2020","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/01.AOG.0000102703.21556.0B","article-title":"Correlation of platelet count with second-look laparotomy results and disease progression in patients with advanced epithelial ovarian cancer","volume":"103","author":"Bozkurt","year":"2004","journal-title":"Obstet. Gynecol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1365-2141.1993.tb04668.x","article-title":"High IL-6 levels in ascitic fluid correlate with reactive thrombocytosis in patients with epithelial ovarian cancer","volume":"83","author":"Gastl","year":"1993","journal-title":"Br. J. Haematol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1873834","DOI":"10.1155\/2017\/1873834","article-title":"Thrombopoietin Secretion by Human Ovarian Cancer Cells","volume":"2017","author":"Besbes","year":"2017","journal-title":"Int. J. Cell Biol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/j.1440-1827.2008.02306.x","article-title":"Increased staining for phosphorylated AKT and nuclear factor-\u03baB p65 and their relationship with prognosis in epithelial ovarian cancer","volume":"58","author":"Guo","year":"2008","journal-title":"Pathol. Int."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/j.1365-2559.2010.03544.x","article-title":"Expression of classical NF-\u03baB pathway effectors in human ovarian carcinoma","volume":"56","author":"Sinn","year":"2010","journal-title":"Histopathology"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.1002\/cncr.25190","article-title":"Nuclear factor \u03baB transcription factors are coexpressed and convey a poor outcome in ovarian cancer","volume":"116","author":"Annunziata","year":"2010","journal-title":"Cancer"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.humpath.2008.10.019","article-title":"Cleaved caspase-3 and nuclear factor-\u03baB p65 are prognostic factors in metastatic serous ovarian carcinoma","volume":"40","author":"Kleinberg","year":"2009","journal-title":"Hum. Pathol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.yexmp.2015.11.030","article-title":"Over-expression of nuclear NF-\u03baB1 and c-Rel correlates with chemoresistance and prognosis of serous epithelial ovarian cancer","volume":"100","author":"Shuang","year":"2016","journal-title":"Exp. Mol. Pathol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s40364-020-00227-y","article-title":"Expression of p52, a non-canonical NF-kappaB transcription factor, is associated with poor ovarian cancer prognosis","volume":"8","author":"Hufnagel","year":"2020","journal-title":"Biomark. Res."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"3260","DOI":"10.1158\/0008-5472.CAN-11-4141","article-title":"Oncogenic PI3K mutations lead to NF-\u03baB-dependent cytokine expression following growth factor deprivation","volume":"72","author":"Hutti","year":"2012","journal-title":"Cancer Res."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s10585-009-9264-9","article-title":"Activated platelets enhance ovarian cancer cell invasion in a cellular model of metastasis","volume":"26","author":"Holmes","year":"2009","journal-title":"Clin. Exp. Metastasis"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"4869","DOI":"10.1182\/blood-2012-06-438598","article-title":"Platelets increase the proliferation of ovarian cancer cells","volume":"120","author":"Cho","year":"2012","journal-title":"Blood"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Cooke, N.M., Spillane, C.D., Sheils, O., O\u2019Leary, J., and Kenny, D. (2015). Aspirin and P2Y12 inhibition attenuate platelet-induced ovarian cancer cell invasion. BMC Cancer, 15.","DOI":"10.1186\/s12885-015-1634-x"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"671","DOI":"10.7150\/jca.7118","article-title":"Aspirin blocks EGF-stimulated cell viability in a COX-1 dependent manner in ovarian cancer cells","volume":"4","author":"Cho","year":"2013","journal-title":"J. Cancer"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4161\/cc.7.1.5103","article-title":"NCX-4016, a nitro-derivative of aspirin, inhibits EGFR and STAT3 signaling and modulates Bcl-2 proteins in cisplatin-resistant human ovarian cancer cells and xenografts","volume":"7","author":"Selvendiran","year":"2008","journal-title":"Cell Cycle"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1158\/1535-7163.MCT-16-0074","article-title":"Antitumor and antiangiogenic effects of aspirin-PC in ovarian cancer","volume":"15","author":"Huang","year":"2016","journal-title":"Mol. Cancer Ther."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1182\/blood-2017-02-769893","article-title":"Role of ADP receptors on platelets in the growth of ovarian cancer","volume":"130","author":"Cho","year":"2017","journal-title":"Blood"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Egan, K., Crowley, D., Smyth, P., O\u2019Toole, S., Spillane, C., Martin, C., Gallagher, M., Canney, A., Norris, L., and Conlon, N. (2011). Platelet adhesion and degranulation induce pro-survival and pro-angiogenic signalling in ovarian cancer cells. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0026125"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1073\/pnas.94.2.663","article-title":"Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets","volume":"94","author":"Green","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.3892\/mmr.2014.3082","article-title":"Platelets are associated with xenograft tumor growth and the clinical malignancy of ovarian cancer through an angiogenesis-dependent mechanism","volume":"11","author":"Yuan","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"20865","DOI":"10.18632\/oncotarget.15348","article-title":"Diabetic concentrations of metformin inhibit platelet-mediated ovarian cancer cell progression","volume":"8","author":"Erices","year":"2017","journal-title":"Oncotarget"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1172\/JCI85086","article-title":"FAK regulates platelet extravasation and tumor growth after antiangiogenic therapy withdrawal","volume":"126","author":"Haemmerle","year":"2016","journal-title":"J. Clin. Investig."},{"key":"ref_87","first-page":"1295","article-title":"Lysis of tumor cells by natural killer cells in mice is impeded by platelets","volume":"59","author":"Nieswandt","year":"1999","journal-title":"Cancer Res."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Orellana, R., Kato, S., Erices, R., Bravo, M.L., Gonzalez, P., Oliva, B., Cubillos, S., Valdivia, A., Iba\u00f1ez, C., and Bra\u00f1es, J. (2015). Platelets enhance tissue factor protein and metastasis initiating cell markers, and act as chemoattractants increasing the migration of ovarian cancer cells. BMC Cancer, 15.","DOI":"10.1186\/s12885-015-1304-z"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1073\/pnas.61.1.46","article-title":"Antimetastatic effects associated with platelet reduction","volume":"61","author":"Gasic","year":"1968","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"14266","DOI":"10.1073\/pnas.1518628112","article-title":"Electron cryotomography reveals ultrastructure alterations in platelets from patients with ovarian cancer","volume":"112","author":"Wang","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"716","DOI":"10.3109\/09537104.2016.1174204","article-title":"Platelets are not hyperreactive in patients with ovarian cancer","volume":"27","author":"Feng","year":"2016","journal-title":"Platelets"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"8015","DOI":"10.1158\/1078-0432.CCR-05-1058","article-title":"Androgen mediation of thrombocytosis in epithelial ovarian cancer biology","volume":"11","author":"Li","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"6083","DOI":"10.1158\/1078-0432.CCR-11-0945","article-title":"Interleukin-6 as a therapeutic target in human ovarian cancer","volume":"17","author":"Coward","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1182\/blood-2011-02-331579","article-title":"S6K1 and mTOR regulate Rac1-driven platelet activation and aggregation","volume":"118","author":"Aslan","year":"2011","journal-title":"Blood"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1038\/onc.2016.323","article-title":"Epithelial-mesenchymal transition of ovarian cancer cells is sustained by Rac1 through simultaneous activation of MEK1\/2 and Src signaling pathways","volume":"36","author":"Fang","year":"2017","journal-title":"Oncogene"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1158\/1078-0432.CCR-14-2279","article-title":"Rac1\/Pak1\/p38\/MMP-2 axis regulates angiogenesis in ovarian cancer","volume":"21","author":"Ivan","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1158\/1535-7163.MCT-15-0419","article-title":"R-ketorolac targets Cdc42 and Rac1 and alters ovarian cancer cell behaviors critical for invasion and metastasis","volume":"14","author":"Guo","year":"2015","journal-title":"Mol. Cancer Ther."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Hudson, L.G., Gillette, J.M., Kang, H., Rivera, M.R., and Wandinger-Ness, A. (2018). Ovarian tumor microenvironment signaling: Convergence on the Rac1 GTPase. Cancers (Basel), 10.","DOI":"10.3390\/cancers10100358"},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Hudson, L.G., Cook, L.S., Grimes, M.M., Muller, C.Y., Adams, S.F., and Wandinger-ness, A. (2019). Dual actions of ketorolac in metastatic ovarian cancer. Cancers (Basel), 11.","DOI":"10.3390\/cancers11081049"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1002\/ijc.28823","article-title":"Non-steroidal anti-inflammatory drugs and cancer risk in women: Results from the Women\u2019s Health Initiative","volume":"135","author":"Brasky","year":"2014","journal-title":"Int. J. Cancer"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"djt431","DOI":"10.1093\/jnci\/djt431","article-title":"Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: A pooled analysis in the ovarian cancer association consortium","volume":"106","author":"Trabert","year":"2014","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/jnci\/djy100","article-title":"Analgesic use and ovarian cancer risk: An analysis in the Ovarian Cancer Cohort Consortium","volume":"111","author":"Trabert","year":"2019","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/0090-8258(83)90160-9","article-title":"Prostacyclin and thromboxane in ovarian cancer: Effect of cytostatics and prostaglandin synthesis inhibitors","volume":"16","author":"Ylikorkala","year":"1983","journal-title":"Gynecol. Oncol."},{"key":"ref_104","first-page":"239","article-title":"NF-\u03baB, macrophage migration inhibitory factor and cyclooxygenase-inhibitions as likely mechanisms behind the acetaminophen- and NSAID-prevention of the ovarian cancer","volume":"51","author":"Altinoz","year":"2004","journal-title":"Neoplasma"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.3324\/haematol.2018.209114","article-title":"The khorana score for prediction of venous thromboembolism in cancer patients: A systematic review and meta-analysis","volume":"104","author":"Mulder","year":"2019","journal-title":"Haematologica"},{"key":"ref_106","unstructured":"ClinicalTrials.gov [Internet] (2020, September 16). Bethesda (MD): National Library of Medicine (US). 29 Feb 2000. Identifier NCT02122185, Metformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02122185?term=NCT02122185&draw=2&rank=1."},{"key":"ref_107","unstructured":"ClinicalTrials.gov [Internet] (2020, September 16). Bethesda (MD): National Library of Medicine (US). 2000 Feb 29. Identifier NCT02437812, Study of Paclitaxel, Carboplatin and Oral Metformin in the Treatment of Advanced Stage Ovarian Carcinoma, Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02437812?term=NCT02437812&draw=2&rank=1."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/21\/8169\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:27:48Z","timestamp":1760178468000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/21\/8169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,31]]},"references-count":107,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2020,11]]}},"alternative-id":["ijms21218169"],"URL":"https:\/\/doi.org\/10.3390\/ijms21218169","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,31]]}}}